Icahn Enterprises Announces Q3 Earnings, Stock Prices Rise
Q3 Financial Performance: Icahn Enterprises reported third-quarter revenue of $2.32 billion, below analyst expectations of $2.40 billion, but earnings per share of 49 cents exceeded estimates of 14 cents. Adjusted EBITDA rose to $383 million from $183 million year-over-year.
Asset Value and Distribution: The company's indicative net asset value increased by $567 million, and a quarterly distribution of 50 cents per depositary unit was declared, set to be paid on December 24 to unitholders of record as of November 17.
Stock Performance: Shares of Icahn Enterprises rose by 7.40% to $8.71 at the time of publication, reflecting positive market sentiment following the financial results.
Investment Options: Investors interested in purchasing IEP stock can do so through brokerage accounts, with options for buying fractional shares. Those looking to short the stock will need access to an options trading platform or a broker that allows short selling.
Trade with 70% Backtested Accuracy
Analyst Views on IEP
About IEP
About the author
Ultra-Rich Family Offices Invested in Struggling Stocks as Market Reached Record Highs Last Quarter
Private Investment Trends: Ultra-wealthy private investment firms capitalized on AI-driven market gains, with notable moves including Appaloosa's exit from Oracle and significant increases in stakes in consumer stocks like Whirlpool and Goodyear.
Carl Icahn's Strategy: Icahn's family office increased its investment in International Flavors & Fragrances by 27%, betting on a recovery for the stock, which has seen a decline this year.
Health Insurance Investments: Leon Cooperman's Omega Advisors expanded its holdings in health insurance stocks, boosting its stakes in Cigna and Elevance Health despite challenges in the healthcare sector.
Tech Stock Engagement: Family offices continued to invest in major tech stocks, with Soros Fund Management significantly increasing its stakes in Apple and Amazon, while Duquesne Family Office re-entered positions in Amazon and Meta.
Hedge Fund Tycoon Carl Icahn's Q3: The Activist Takes a Defensive Stance, Sells Off a Troubling Investment, and Increases Stake in EchoStar
Icahn's Portfolio Reshuffle: Carl Icahn's latest 13F filing reveals a $9.14 billion portfolio, showcasing a significant reshuffle, including the complete liquidation of his stake in Bausch Health Companies, which had dropped 75%.
New Investments: Icahn made a notable investment in EchoStar Corp, acquiring 4.35 million shares, making it one of his top five positions, alongside increased stakes in Centuri Holdings and International Flavors & Fragrances.
Concentration in Holdings: Despite the changes, Icahn's portfolio remains highly concentrated, with 98.5% of capital in just 10 stocks, and nearly 48% tied to Icahn Enterprises, which he continues to invest in despite its significant decline.
Strategic Outlook: Icahn's moves indicate a shift in strategy, as he exits underperforming investments while doubling down on perceived value opportunities, reflecting his long-term conviction in his core holdings.
